Shanghai Pharmaceuticals' (SHA:601607, HKG:2607) unit, Shanghai Pharmaceuticals Group Qingdao Guofeng Pharmaceutical, obtained a drug registration certificate from China's National Medical Products Administration for the Wenjing decoction granules, according to a Thursday filing with the Shanghai Stock Exchange.
The Chinese traditional medicine is used for various purposes, such as relieving pain and balancing blood circulation for women with irregular menstruation and lower abdominal pain.
The pharmaceutical company invested 4.7 million yuan in the drug's research and development, the filing said.